Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Patrick Poulin is a writer and advertising copywriter. He previously practiced as a tax and business lawyer for 17+ years. SOPA Images / Getty Images Ernst & Young is made up of three regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results